Clicks Group (CLS.JO) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $26.61M | Exchange | JNB |
| Sector | Healthcare | Industry | Medical - Pharmaceuticals |
| Country | ZA | CEO | Bertina D. Engelbrecht B.Proc |
| IPO Date | 2000-01-04 | CAGR | 10.2% |
| Employees | 20,682 | Website | www.clicksgroup.co.za |
| Div. Yield | — | Payout Ratio | 62% |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $77.73B | P/E | 13.19 | Forward P/E | 1176.51 | PEG | 1.59 |
| P/S | 0.02 | P/B | 0.02 | P/CF | 0.02 | P/FCF | 0.03 |
| Sales | $6.17B | Sales 1Y | 15.52% | Sales 3Y | 58.69% | Sales 5Y | 131.13% |
| EPS | $0.01 | EPS 1Y | 23.74% | EPS 3Y | 103.97% | EPS 5Y | 245.03% |
| Sales QoQ | 0.66% | EPS QoQ | -14.08% | Sales QoQ Avg | 5.23% | EPS QoQ Avg | 6.82% |
| Gross Margin | 25.26% | Operating Margin | 9.09% | Profit Margin | 6.26% | ROCE | 51.9% |
| ROA | 14% | ROE | 51% | Altman Z Score | 8.17 | Piotroski Score | 7 |
| Current Ratio | 1.05 | Quick Ratio | 0.39 | Cash Ratio | 0.09 | Op. CF Ratio | 0.08 |
| Debt/Equity | 0.72 | Debt/Assets | 0.19 | Lt Debt/Equity | 0.49 | Lt Debt/Cap. | — |
| Intrst Cov. | 12.57 | Inventory Turnover | 4.4 | Asset Turnover | 2.31 | Receivables Turnover | 12.85 |
| Enterprise Value | $77.73B | P/E Ratio | 13.19 |
| Forward P/E | 1176.51 | PEG Ratio | 1.59 |
| P/S Ratio | 0.02 | P/B Ratio | 0.02 |
| P/CF Ratio | 0.02 | P/FCF Ratio | 0.03 |
| EPS | $0.01 | EPS Growth 1Y | 23.74% |
| EPS Growth 3Y | 103.97% | EPS Growth 5Y | 245.03% |
| Revenue Growth 1Y | 15.52% | Gross Margin | 0.25% |
| Operating Margin | 0.09% | Profit Margin | 0.06% |
| ROE | 0.51% | ROA | 0.14% |
| ROCE | 0.52% | Current Ratio | 1.05 |
| Quick Ratio | 0.39 | Cash Ratio | 0.09 |
| Debt/Equity | 0.72 | Interest Coverage | 12.57 |
| Altman Z Score | 8.17 | Piotroski Score | 7 |
Clicks Group (CLS.JO) valuation & financials
Clicks Group (CLS.JO) has a market capitalization of 26.61M ZAC and trades at a price-to-earnings ratio of 13.2. It operates in the Healthcare sector (Medical - Pharmaceuticals).
Clicks Group's revenue grew +15.5% over the last year.
Clicks Group's next earnings report is scheduled for October 22, 2026. Check the earnings calendar to see all companies reporting this week.
Clicks Group (CLS.JO) — frequently asked questions
When does Clicks Group (CLS.JO) report earnings next?
Clicks Group is expected to report earnings on October 22, 2026.
What is Clicks Group's market cap?
Clicks Group (CLS.JO) has a market capitalization of 26.61M ZAC.
What is CLS.JO's P/E ratio?
Clicks Group trades at a price-to-earnings ratio of 13.2, with trailing twelve-month EPS of 0.01 ZAC.
How fast is Clicks Group growing?
Clicks Group's revenue grew +15.5% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)